PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Hepatic & Biliary Function/ALP
Hepatic & Biliary FunctionBiliary Canalicular Membrane & Osteoblastic Turnover

Alkaline Phosphatase (ALP)

Alkaline phosphatase is a zinc- and magnesium-dependent metalloenzyme located on the canalicular membrane of hepatocytes and the plasma membrane of osteoblasts.

Standard Range44 - 147 U/L
Optimal Longevity50 - 85 U/L
Measurement UnitU/L
Organ SystemBiliary Canalicular Membrane & Osteoblastic Turnover
Routine Panels:CMPHepatic Function PanelYale PhenoAge Input

Standard vs. Optimal Reference RangesU/L

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: U/L
U/L
Presets:
30 U/LOptimal Zone Target199 U/L
Optimal Longevity Zone(67.5 U/L)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

44 - 147 U/L

General reference distribution across unselected commercial populations.

Optimal Longevity Target

50 - 85 U/L

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Hydrolyzes organic monophosphates at alkaline pH. Biliary obstruction induces canalicular synthesis of hepatic ALP; active bone remodeling (osteoblasts) releases bone ALP isoenzyme into plasma.

Differential Diagnosis

Elevated Levels (ALP High)

  • •Cholestasis / Biliary tract obstruction (gallstones, stricture)
  • •Bone disease with high osteoblastic activity (Paget disease, healing fractures, osteomalacia)
  • •Pregnancy (placental isoenzyme)

Low Levels (ALP Low)

  • •Zinc or magnesium deficiency (obligate enzyme cofactors)
  • •Severe malnutrition
  • •Wilson disease / Hypophosphatasia

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
Alkaline Phosphatase (ALP) reflects hepatocyte integrity, biliary canalicular transport, and hepatic synthetic capacity. Hepatic parenchymal cells synthesize proteins, metabolize xenobiotics via cytochrome P450 monooxygenases, and conjugate endogenous substrates via UDP-glucuronosyltransferases. Cellular membrane disruption from lipid peroxidation, bile acid toxicity, or immune-mediated cytolysis releases intracellular enzymes into systemic circulation. Synthesis rates of carrier proteins depend directly on ribosomal transcription and functional hepatic mass.
Longevity Risk Architecture & Epidemiology
Alkaline phosphatase is an integral variable in the Yale PhenoAge clock. Higher baseline ALP within the normal range reflects subclinical vascular calcification, bone turnover, or low-grade biliary stasis.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

A 12-hour overnight fast is recommended, especially if assessing biliary markers or lipid-associated hepatic enzymes. Complete abstinence from ethanol for at least 48 to 72 hours prior to testing is mandatory to prevent enzyme induction. Avoid strenuous unaccustomed weightlifting for 48 hours prior, which can release muscular transaminases and elevate AST/ALT.

Reflexive Testing Protocol:

  • Comprehensive Hepatic Viral Panel (Hepatitis A IgM, HBsAg, HBcAb, HCV antibody with reflex PCR)
  • Vibration-Controlled Transient Elastography (FibroScan) or Magnetic Resonance Elastography to quantify hepatic fat and fibrosis
  • Serum Ferritin and Total Iron-Binding Capacity (TIBC) to screen for hereditary hemochromatosis
  • Autoimmune Liver Disease Serology (Anti-Nuclear Antibodies, Anti-Smooth Muscle Antibodies, Anti-Mitochondrial Antibodies)
  • Abdominal Right Upper Quadrant Ultrasound to assess hepatic parenchyma, biliary ducts, and portal vein flow
Clinical Citations & Primary Literature (1)
  • [1]Alkaline Phosphatase: Beyond Hepatic and Bone Disease into Vascular Aging - Arteriosclerosis, Thrombosis, and Vascular Biology (2021). PMID: 33792215
Common Panels:CMPHepatic Function PanelYale PhenoAge Input
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Alkaline Phosphatase (ALP) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Hepatic & Biliary Function Biomarkers

Gamma-Glutamyl Transferase
GGT · 10 - 20 U/L
Total Serum Bilirubin
T-Bilirubin · 0.6 - 1.2 mg/dL (Mild elevation in Gilbert's is longevity-protective)
Serum Albumin
Albumin · 4.5 - 5.0 g/dL
Yale PhenoAge (Levine Biological Age Clock)
PhenoAge · < Chronological Age (Negative Phenotypic Age Acceleration)
PreviousAST to ALT Ratio (De Ritis Ratio) (AST/ALT Ratio)Hepatic & Biliary FunctionNextGamma-Glutamyl Transferase (GGT)Hepatic & Biliary Function